Sign in
Enrolling by invitationNo phase

Imaging to understand how the Cryosa Procedure works for obstructive sleep apnea

Studies scans and measurements in adults with obstructive sleep apnea having the Cryosa Procedure.

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea
Status
Enrolling by invitation
People taking part
10 people, planned
Started
12 Jun 2024
Expected to end
Aug 2030
Type of study
Observational
Treatments tested
  • Cryosa Procedure
Record updated
31 October 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with obstructive sleep apnea who take part in the ARCTIC-3 trial and are having the Cryosa Procedure. They have MRI and ultrasound scans before and after the procedure.

Sex
All sexes can join.
Disease stage
Obstructive sleep apnea in adults.
Earlier treatment
People must be enrolled in the ARCTIC-3 clinical trial at the University of Pennsylvania.

Main reasons for not taking part

  • People who cannot have an MRI, for example because of fear of closed spaces or metal implants or objects in the body
  • People who are pregnant or become pregnant during the study

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Enrolled in the ARCTIC-3 clinical trial at the University of Pennsylvania*
  • Provision of signed and dated informed consent form for ICE-OSA

Who cannot take part

  • MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)
  • Patient is pregnant or becomes pregnant during their enrollment

Where in United States

  • University of PennsylvaniaPhiladelphia, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The goal of this observational study is to further evaluate the efficacy and mechanism of action of the Cryosa Procedure, a novel procedure intended to treat obstructive sleep apnea (OSA). The patient population includes participants with OSA who are enrolled in the ARCTIC-3 study and are undergoing the Cryosa Procedure. The main questions to be answered are:

Read full original descriptionShow less

(1) evaluate predictors of successful treatment with the Cryosa Procedure, which is described in more detail in the ARCTIC-3 protocol (IRB #854182), and (2) evaluate a potential mechanism of action of this novel therapy.

The study team hypothesizes that higher baseline quantities of oropharyngeal fat and higher baseline upper airway neurotonic activity will be correlated with a successful reduction in OSA symptom severity as measured by a change in apnea-hypopnea index values. The study team also hypothesizes that responders will have a decrease in oropharyngeal fat, which would indicate the mechanism of action of this novel therapy is a loss in oropharyngeal fat.

Participants will be asked to:

1. have an MRI before undergoing the Cryosa Procedure 2. have an ultrasound before the Cryosa Procedure 3. permit the use of pressure-sensing catheters and ultrasound during their drug-induced sleep endoscopy, which is part of the ARCTIC-3 protocol 4. have an MRI after the Cryosa Procedure 5. have an ultrasound after the Cryosa Procedure.

Treatments tested

  • Cryosa Procedure

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea
Plain-language title
Imaging to understand how the Cryosa Procedure works for obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
31 October 2025